D., Wang, Z
This dual mechanism has shown superior weight loss results in clinical trials
Oral semaglutide was superior to placebo, sitagliptin, and liraglutide and similar to empagliflozin, with losses up to 4.44 kg compared with 0.53.6 kg for active-comparator arms and 0.41.4 kg compared with placebo [35,36,37,38,39,40]
Sin embargo, durante la ltima dcada, numerosos estudios han acumulado evidencia de la utilidad del ultrasonido gstrico para la evaluacin del contenido gstrico, resultando especialmente til en situaciones donde el ayuno se vuelve un mal predictor de un vaciamiento gstrico completo[9]
The data are clear: patients who stop taking their GLP-1 after weight loss regain about two-thirds of the weight they lost
DOI 10.1172/jci.insight.124865